This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

AbbVie Inc (ABBV)

NYSE: Health Care

Company Balance Sheet
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Cash and Equivalents 8.35B 9.60B 5.90B 27.48M
Receivables 4.29B 4.80B 4.30B 3.82B
Inventories 1.12B 1.15B 1.09B 871.58M
Other Current Assets 0.00 0.00 0.00 0.00
Total Current Assets 16.09B 17.85B 15.35B 7.35B
Property, Plant & Equipment, Gross 7.11B 6.91B 6.54B 5.95B
Accumulated Depreciation & Depletion 4.62B 4.61B 4.29B 3.80B
Property, Plant & Equipment, Net 2.48B 2.30B 2.25B 2.14B
Intangibles 1.51B 1.89B 2.32B 2.91B
Other Non-Current Assets 1.60B 885.00M 954.00M 229.34M
Total Non-Current Assets 11.46B 11.35B 11.65B 12.30B
Liabilities & Shareholder Equity
Total Assets 27.55B 29.20B 27.01B 19.66B
Accounts Payable 1.42B 3.21B 3.10B 417.03M
Short Term Debt 4.45B 431.00M 1.04B 0.00
Other Current Liabilities 791.00M 2.17B 0.00 0.00
Total Current Liabilities 11.40B 6.88B 6.78B 5.90B
Long Term Debt 10.56B 14.29B 14.63B 0.00
Deferred Income Taxes 630.00M 570.00M 0.00 0.00
Other Non-Current Liabilities 3.21B 2.96B 2.24B 1.54B
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 14.40B 17.83B 16.87B 1.54B
Total Liabilities 25.80B 24.71B 23.64B 7.43B
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 1.74B 4.49B 3.36B 12.22B
Common Par 16.00M 16.00M 3.71B 0.00
Additional Paid In Capital 4.19B 3.67B 0.00 0.00
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings 535.00M 1.57B 0.00 0.00
Treasury Stock -972.00M -320.00M 0.00 0.00
Other Equity Adjustments -2.03B -442.00M -350.00M 12.22B
Total Capitalization 12.31B 18.78B 17.99B 12.22B
Total Equity 1.74B 4.49B 3.36B 12.22B
Total Liabilities & Stock Equity 27.55B 29.20B 27.01B 19.66B
Total Common Shares Outstanding 1.59B 1.59B 1.58B 1.58B
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 18.13M 6.90M 0.00 0.00
Basic Weighted Shares Outstanding 1.59B 1.59B 1.58B 0.00
Diluted Weighted Shares Outstanding 1.61B 1.60B 1.58B 0.00
Number of Employees 26000 25000 21500 NA
Number of Part-Time Employees 0 0 0 NA

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

Analysts Ratings for ABBV

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 10 10 9 10
Moderate Buy 1 0 0 0
Hold 1 2 2 2
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0

ABBV Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs